IL44135A - Anticancer medicament containing human serum - Google Patents

Anticancer medicament containing human serum

Info

Publication number
IL44135A
IL44135A IL44135A IL4413574A IL44135A IL 44135 A IL44135 A IL 44135A IL 44135 A IL44135 A IL 44135A IL 4413574 A IL4413574 A IL 4413574A IL 44135 A IL44135 A IL 44135A
Authority
IL
Israel
Prior art keywords
serum
medicament
hepatitis
blood
antigen
Prior art date
Application number
IL44135A
Other languages
English (en)
Other versions
IL44135A0 (en
Original Assignee
Soussan A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soussan A filed Critical Soussan A
Publication of IL44135A0 publication Critical patent/IL44135A0/xx
Publication of IL44135A publication Critical patent/IL44135A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32432Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL44135A 1973-02-19 1974-02-04 Anticancer medicament containing human serum IL44135A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7305741A FR2218091B1 (fr) 1973-02-19 1973-02-19

Publications (2)

Publication Number Publication Date
IL44135A0 IL44135A0 (en) 1974-06-30
IL44135A true IL44135A (en) 1976-12-31

Family

ID=9115016

Family Applications (1)

Application Number Title Priority Date Filing Date
IL44135A IL44135A (en) 1973-02-19 1974-02-04 Anticancer medicament containing human serum

Country Status (13)

Country Link
AT (1) AT339473B (fr)
AU (1) AU6575874A (fr)
BE (1) BE810112A (fr)
DE (1) DE2404983A1 (fr)
ES (1) ES423245A1 (fr)
FR (1) FR2218091B1 (fr)
GB (1) GB1465553A (fr)
IL (1) IL44135A (fr)
LU (1) LU69412A1 (fr)
MC (1) MC1000A1 (fr)
NL (1) NL7401983A (fr)
OA (1) OA04602A (fr)
ZA (1) ZA74655B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685870B1 (fr) * 1992-01-03 1995-07-07 Soussan Andre Medicament anticancereux.

Also Published As

Publication number Publication date
AT339473B (de) 1977-10-25
OA04602A (fr) 1980-06-30
FR2218091A1 (fr) 1974-09-13
AU6575874A (en) 1975-08-21
DE2404983A1 (de) 1974-10-17
ZA74655B (en) 1975-09-24
MC1000A1 (fr) 1974-10-18
ATA129774A (de) 1977-02-15
ES423245A1 (es) 1976-05-01
LU69412A1 (fr) 1974-05-29
GB1465553A (en) 1977-02-23
NL7401983A (fr) 1974-08-21
FR2218091B1 (fr) 1976-07-02
IL44135A0 (en) 1974-06-30
BE810112A (fr) 1974-05-16

Similar Documents

Publication Publication Date Title
Suciu-Foca et al. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer
Ferguson et al. Jejunal mucosal abnormalities in patients with recurrent aphthous ulceration.
Bass Behavior of eosinophil leukocytes in acute inflammation. I. Lack of dependence on adrenal function.
EP0181364A1 (fr) Compositions pour soulager, traiter et diagnostiquer des maladies arthritiques et des etats relatifs a celles-ci.
Cassel et al. Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses
Castaldi et al. Studies of the life span and fate of platelets
Thomas Jr et al. Demonstration of Infectious Hepatitis Virus in Presymptomatic Period after Transfer by Transfusion.∗
Francis Jr Differentiation of Influenza A and Influenza B by the Complement-Fixation Reaction.
Turner et al. Hemagglutinating virus isolated from cat scratch disease
IL44135A (en) Anticancer medicament containing human serum
Penhale et al. The immunodepressive effect of rinderpest virus
Hayes et al. Influence of propranolol on weight and salt and water homoeostasis in chronic liver disease
Phillips et al. Passive Transfer of Immunity to Sarcoma I with Serum.
Aronson et al. The comparison of some tuberculins in BCG-vaccinated and unvaccinated persons
Weir et al. Intrinsic factor secretion in response to continuous histamine infusion
Graw Jr et al. Priapism in a child with chronic granulocytic leukemia
Sorensen et al. Antigenic fractions specific for Histoplasma capsulatum in the complement fixation reaction
Freestone et al. Transient monoclonal gammopathy in hydralazine-induced lupus erythematosus
Ireton et al. The covert liver disease of drug addicts
JPS63316736A (ja) 抗レトロウィルス剤
Kamat et al. Typhoid: Clinical picture and response to chloramphenicol: Prospective study in Bombay (1972)
Driessen et al. Haemadsorption in vaccinia-infected tube tissue cultures
Ward OBSERVATIONS ON THE PHAGOCYTOSIS OF THE PNEUMOCOCCUS BY HUMAN WHOLE BLOOD: II. THE NEUTRALIZATION OF THE ANTI-PHAGOCYTIC ACTION OF THE SPECIFIC SOLUBLE SUBSTANCE BY ANTISERUM
Wallace et al. Some clinical implications of the protein binding of digoxin
Raghupati Sarma et al. Determination of acetylator phenotype based on the ratio of acetylisoniazid to isoniazid in urine following an oral dose of ordinary isoniazid